Today: 7 February 2026
Subscribe

Rolls-Royce share price slips as £200m buyback grinds on and valuation debate returns

Rolls-Royce share price slips as £200m buyback grinds on and valuation debate returns

Rolls-Royce shares fell 1.3% to 1,264 pence in early London trading after the company disclosed further buybacks under its £200 million programme. The drop follows a sharp rally that pushed the stock to a twelvefold gain since January 2023. Analysts flagged the forward P/E ratio at 44.2 as “exceptionally high” ahead of full-year results due Feb. 26.
21 January 2026
····
Ashtead share price rebounds as AHT buybacks continue, with March 2 NYSE move in focus

Ashtead share price rebounds as AHT buybacks continue, with March 2 NYSE move in focus

Ashtead shares rose 1% to 5,050 pence in early London trading Wednesday after two days of declines. The company confirmed a new $1.5 billion buyback programme starting March 2, coinciding with its planned NYSE relisting. Ashtead bought 74,800 shares on Jan. 20 and 74,000 on Jan. 19, both via J.P. Morgan Securities. Investors are watching for updates on the relisting schedule.
21 January 2026
·····
Netflix stock slips premarket as Warner Bros bid swamps earnings beat

Netflix stock slips premarket as Warner Bros bid swamps earnings beat

Netflix shares fell 1.1% premarket after the company reported a slight earnings beat but warned of higher deal-related costs tied to its $82.7 billion all-cash bid for Warner Bros Discovery assets. The company will halt share buybacks to conserve cash for the deal. Netflix posted $12.1 billion in fourth-quarter revenue, topping estimates, and paid subscribers rose above 325 million. Shares dropped about 7% in early Frankfurt trading.
21 January 2026
······
Haleon share price rises as Jefferies lifts target and investors eye results

Haleon share price rises as Jefferies lifts target and investors eye results

Haleon shares rose 1.4% to 378.2 pence in early London trading Wednesday after Jefferies raised its price target to 450 pence and reaffirmed a buy rating. The company reiterated its 2025 guidance for about 3.5% organic revenue growth, warning that currency translation could reduce net revenue by 2.8% and profit by 3.8% for the year.
21 January 2026
·····
Rio Tinto stock price rises as bumper Q4 output beats forecasts and puts focus back on February

Rio Tinto stock price rises as bumper Q4 output beats forecasts and puts focus back on February

Rio Tinto shares climbed 3.5% to 6,535 pence after reporting stronger-than-expected fourth-quarter output, with Pilbara iron ore shipments hitting a record 91.3 million tonnes. Copper production rose 11% to 883,000 tonnes for 2025, boosted by Oyu Tolgoi. The STOXX 600 slipped 0.1%. Investors await Rio’s full-year results and a merger decision with Glencore by Feb. 5.
21 January 2026
·····
Experian share price slides 5% after Q3 trading update keeps outlook unchanged — what to watch next

Experian share price slides 5% after Q3 trading update keeps outlook unchanged — what to watch next

Experian shares fell 5.3% to 3,055 pence in early London trading Wednesday after its third-quarter update, despite reporting 8% organic revenue growth and maintaining its full-year outlook. The stock touched a 52-week low of 3,032 pence. Investors are watching U.S. lending and mortgage trends for signs of momentum shifts.
21 January 2026
·····
RELX share price slides near 52-week low as buyback update and LexisNexis AI push meet trade jitters

RELX share price slides near 52-week low as buyback update and LexisNexis AI push meet trade jitters

RELX shares fell 1.4% to 2,967 pence by 0915 GMT Wednesday, nearing a 52-week low amid renewed U.S.-Europe trade tensions and higher UK inflation. The company disclosed a buyback of 314,016 shares Tuesday, now holding over 8.1 million in treasury. LexisNexis expanded its Protégé AI tool, while investors await RELX’s full-year results on Feb. 12.
21 January 2026
·····
GSK stock slips after $2.2 billion RAPT deal — what investors watch before the open

GSK stock slips after $2.2 billion RAPT deal — what investors watch before the open

GSK’s U.S.-listed shares fell 1.2% to $47.65 premarket after it agreed to buy RAPT Therapeutics for $2.2 billion, paying a 65% premium for rights to a mid-stage food allergy drug. The deal, led by new CEO Luke Miels, comes as GSK faces pressure to offset losses from expiring HIV drug patents. Pfizer will exit the ViiV Healthcare joint venture, with Shionogi raising its stake to 21.7%.
21 January 2026
·····
BAT share price today: British American Tobacco edges up after buyback update, steadies after Tuesday drop

BAT share price today: British American Tobacco edges up after buyback update, steadies after Tuesday drop

British American Tobacco shares rose 0.1% to 4,262 pence in early London trading after a 2.65% drop the previous day. The company said it repurchased 160,365 shares on Jan. 20 for cancellation. UK inflation rose to 3.4% in December, with tobacco costs contributing. BAT’s next results are due Feb. 12.
21 January 2026
·····
1 … 477 478 479 480 481 … 2,713

Stock Market Today

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop